CAPN2 and Insulin resistance: Metformin may inhibit the release of calpain 2 from exosomes, interfere with IR splitting (through the pathway of knocking out calpain 2 and γ-secretase), restore the functions of IRS-1 and Akt, and re-establish insulin signaling, thereby alleviating insulin resistance, enhance insulin sensitivity.